Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that Eric Dube, Ph.D., president and chief executive officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, ...

Received 693 new patient start forms for FILSPARI® (sparsentan) in the fourth quarter of 2024; approximately $50 million in preliminary net product sales of FILSPARI for the fourth quarter ...

ASN Kidney Week, held in November, featured leading-edge science in kidney care, with evidence supporting new drugs to treat ...

Detailed price information for Travere Therapeutics Inc (TVTX-Q) from The Globe and Mail including charting and trades.

Boston Scientific Corporation tops the list with its strong position in the medical device market. The company’s cardiovascular, rhythm management, and endoscopy product lines have positioned it as a ...

Abbott will announce its fourth-quarter 2025 financial results on Thursday, Jan. 22, before the market opens. The announcement will be followed by a live webcast of the earnings conference call at 8 a ...

Hisense, a leading brand in global consumer electronics and home appliances, today hosted its CES 2026 press conference under the theme "Innovating a Brighter Life," showcasing its latest advances in ...

Dr Gaia Coppock examines approaches to guide colleagues and patients through the quickly changing landscape of IgA ...

Dr Gaia Coppock comments on how collaborative care among nephrologists is transforming glomerular disease treatment.